MENU
SRZN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Surrozen (SRZN) Earnings Date & Reports

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues... Show more

A.I. Advisor
published Earnings

SRZN is expected to report earnings to rise 158.54% to -105 cents per share on November 11

Surrozen SRZN Stock Earnings Reports
Q3'26
Est.
$-1.06
Q2'26
Beat
by $0.88
Q1'26
Missed
by $10.66
Q4'25
Missed
by $18.10
Q2'25
Beat
by $3.16
The last earnings report on August 06 showed earnings per share of -40 cents, beating the estimate of -128 cents. With 174.30K shares outstanding, the current market capitalization sits at 348.38M.